These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34044551)

  • 41. Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    Navarria P; Pessina F; Clerici E; Rossini Z; Franceschini D; D'Agostino G; Franzese C; Comito T; Loi M; Simonelli M; Lorenzi E; Persico P; Politi LS; Grimaldi M; Bello L; Santoro A; Fornari M; Servadei F; Scorsetti M
    J Neurosurg; 2021 Jul; 135(1):64-77. PubMed ID: 32886916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.
    Tabei Y; Kobayashi K; Saito K; Shimizu S; Suzuki K; Sasaki N; Shiokawa Y; Nagane M
    Jpn J Clin Oncol; 2021 Jan; 51(1):45-53. PubMed ID: 32888020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years.
    Niu X; Wang T; Zhou X; Yang Y; Wang X; Zhang H; Chen N; Yue Q; Wang F; Zhang Y; Liu Y; Mao Q
    J Neurooncol; 2020 Apr; 147(2):377-386. PubMed ID: 32157551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
    Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
    World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma.
    Jungk C; Warta R; Mock A; Friauf S; Hug B; Capper D; Abdollahi A; Debus J; Bendszus M; von Deimling A; Unterberg A; Herold-Mende C
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review.
    Weng JC; Li D; Wang L; Wu Z; Wang JM; Li GL; Jia W; Zhang LW; Zhang JT
    J Neurosurg; 2019 Sep; 131(3):695-705. PubMed ID: 30497189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Prognostic Value of MRI Subventricular Zone Involvement and Tumor Genetics in Lower Grade Gliomas.
    Chiang GC; Pisapia DJ; Liechty B; Magge R; Ramakrishna R; Knisely J; Schwartz TH; Fine HA; Kovanlikaya I
    J Neuroimaging; 2020 Nov; 30(6):901-909. PubMed ID: 32721076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
    Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
    Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting TERT promoter mutation using MR images in patients with wild-type IDH1 glioblastoma.
    Yamashita K; Hatae R; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Yamashita Y; Kuga D; Hata N; Yoshimoto K; Suzuki SO; Iwaki T; Iihara K; Honda H
    Diagn Interv Imaging; 2019; 100(7-8):411-419. PubMed ID: 30948344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased survival in glioblastomas is specific to contact with the ventricular-subventricular zone, not subgranular zone or corpus callosum.
    Mistry AM; Dewan MC; White-Dzuro GA; Brinson PR; Weaver KD; Thompson RC; Ihrie RA; Chambless LB
    J Neurooncol; 2017 Apr; 132(2):341-349. PubMed ID: 28074322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
    Zinn PO; Colen RR; Kasper EM; Burkhardt JK
    Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.
    Yang K; Man W; Jing L; Sun Z; Liang P; Wang J; Wang G
    World Neurosurg; 2020 Nov; 143():e157-e165. PubMed ID: 32688042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
    Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
    Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of subventricular zone involvement in extent of resection and tumor growth pattern of glioblastoma.
    Ahmadipour Y; Krings JI; Rauschenbach L; Gembruch O; Chihi M; Darkwah Oppong M; Pierscianek D; Jabbarli R; Sure U; El Hindy N
    Innov Surg Sci; 2020 Sep; 5(3-4):127-132. PubMed ID: 34966832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[
    Harat M; Małkowski B; Roszkowski K
    Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does the expression of glial fibrillary acid protein (GFAP) stain in glioblastoma tissue have a prognostic impact on survival?
    Ahmadipour Y; Gembruch O; Pierscianek D; Sure U; Jabbarli R
    Neurochirurgie; 2020 Jun; 66(3):150-154. PubMed ID: 32278699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
    Li H; Li J; Cheng G; Zhang J; Li X
    Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.